Farrell Simon - Net Worth and Insider Trading

Farrell Simon Net Worth

The estimated net worth of Farrell Simon is at least $533,302 dollars as of 2025-07-22. Farrell Simon is the Chief Commercial Officer of Trevi Therapeutics Inc and owns about 76,900 shares of Trevi Therapeutics Inc (TRVI) stock worth over $533,302. Details can be seen in Farrell Simon's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Farrell Simon has not made any transactions after 2025-03-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Farrell Simon

To

Farrell Simon Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Farrell Simon owns 1 companies in total, including Trevi Therapeutics Inc (TRVI) .

Click here to see the complete history of Farrell Simon’s form 4 insider trades.

Insider Ownership Summary of Farrell Simon

Ticker Company Transaction Date Type of Owner
TRVI Trevi Therapeutics Inc 2025-03-10 Chief Commercial Officer

Farrell Simon Latest Holdings Summary

Farrell Simon currently owns a total of 1 stock. Farrell Simon owns 76,900 shares of Trevi Therapeutics Inc (TRVI) as of March 10, 2025, with a value of $533,302.

Latest Holdings of Farrell Simon

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TRVI Trevi Therapeutics Inc 2025-03-10 76,900 6.94 533,302

Holding Weightings of Farrell Simon


Farrell Simon Form 4 Trading Tracker

According to the SEC Form 4 filings, Farrell Simon has made a total of 1 transactions in Trevi Therapeutics Inc (TRVI) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Trevi Therapeutics Inc is the sale of 81,313 shares on March 10, 2025, which brought Farrell Simon around $548,863.

Insider Trading History of Farrell Simon

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Farrell Simon Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Farrell Simon Ownership Network

Ownership Network List of Farrell Simon

No Data

Ownership Network Relation of Farrell Simon

Insider Network Chart


Farrell Simon Owned Company Details

What does Trevi Therapeutics Inc do?

Who are the key executives at Trevi Therapeutics Inc?

Farrell Simon is the Chief Commercial Officer of Trevi Therapeutics Inc. Other key executives at Trevi Therapeutics Inc include 10 percent owner & Chief Medical Officer Thomas Sciascia , director & 10 percent owner & See Remarks Jennifer L Good , and director & 10 percent owner David P Meeker .

Trevi Therapeutics Inc (TRVI) Insider Trades Summary

Over the past 18 months, Farrell Simon made 1 insider transaction in Trevi Therapeutics Inc (TRVI) with a net sale of 81,313. Other recent insider transactions involving Trevi Therapeutics Inc (TRVI) include a net sale of 96,058 shares made by Jennifer L Good , a net sale of 104,000 shares made by Thomas Sciascia , and a net sale of 4,555 shares made by David P Meeker .

In summary, during the past 3 months, insiders sold 0 shares of Trevi Therapeutics Inc (TRVI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 290,276 shares of Trevi Therapeutics Inc (TRVI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 290,276 shares.

Trevi Therapeutics Inc (TRVI)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Trevi Therapeutics Inc Insider Transactions

No Available Data

Farrell Simon Mailing Address

Above is the net worth, insider trading, and ownership report for Farrell Simon. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Farrell Simon's mailing address is: New Haven Ct 06510.